PROM1 and neoplasm: Although pancreatic CSCs were described nearly ten years ago as CD44+/ CD24+/EpCAM+ cells [3] or CD133+ cells [4], no study has determined the co-expression of all of these markers in PDAC either directly in the tumor samples or in the human PDAC cell lines derived from primary tumors.